Sign in

CIK 0001582313

  • Large accelerated filer

Xenon Pharmaceuticals Inc.

Sign in to watch
Ticker
XENE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980661854
Phone
+1 604-484-3300
Business address
200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
Open-market buys, last 90 days
$1,681,140
in 2 filings
Open-market sales, last 90 days
$425,829
in 1 filing, $426K under 10b5-1 plans

Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-06-01 HOLLER FRANK A Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2020-06-01 PIMSTONE SIMON N. CEO Sale −3,000 $14.43 $43K 255,186
2020-05-29 HOLLER FRANK A Director Exercise or conversion +3,086 $3.56 $11K 122,041
2020-05-29 HOLLER FRANK A Director Exercise or conversion · Stock Option (Right to Buy) −3,086 0
2020-05-29 PIMSTONE SIMON N. CEO Sale −5,000 $13.99 $70K 258,186
2020-05-26 PIMSTONE SIMON N. CEO Exercise or conversion +6,172 $3.56 $22K 264,294
2020-05-26 PIMSTONE SIMON N. CEO Shares withheld for taxes −1,108 $14.90 $17K 263,186
2020-05-26 PIMSTONE SIMON N. CEO Exercise or conversion · Stock Option (Right to Buy) −6,172 0
2020-03-12 EMPFIELD JAMES R. SVP, Drug Discovery Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-03-12 ROBIN SHERRINGTON EVP, Strategy & Innovation Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-03-12 AYCARDI-FONSECA ERNESTO CMO Grant or award · Stock Option (Right to Buy) +65,000 65,000
2020-03-12 MORTIMER IAN PRESIDENT & CFO Grant or award · Stock Option (Right to Buy) +145,000 145,000
2020-03-12 PIMSTONE SIMON N. CEO Grant or award · Stock Option (Right to Buy) +280,000 280,000
2020-01-13 Desjardins Clarissa Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2019-12-16 AZAB MOHAMMAD Director Exercise or conversion +3,086 $3.56 $11K 60,647
2019-12-16 AZAB MOHAMMAD Director Exercise or conversion · Stock Option (Right to Buy) −3,086 0
2019-12-04 PATOU GARY Director Exercise or conversion +2,057 $3.56 $7K 21,516
2019-12-04 PATOU GARY Director Exercise or conversion · Stock Option (Right to Buy) −2,057 0
2019-11-21 TARNOW MICHAEL M Director Exercise or conversion +5,144 $3.56 $18K 69,713
2019-11-21 TARNOW MICHAEL M Director Gift −5,144 64,569

Page 23 of 27 · 536 trades